SyntekaBio,Inc. Q3 operating loss of KRW 3.7 billion on revenue of KRW 0.7 billion
AI summary · Not investment advice
In Q3, the company sold KRW 0.7 billion worth and lost KRW 3.7 billion from its main business, versus KRW 0.5 billion in sales and a KRW 2.3 billion loss a year earlier.
Operating profit · 3 months
KRW -3.7 billion
Key facts
- Revenue (3 months)
- KRW 689.3 million
- Net income (3 months)
- KRW -4.3 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (prior-year 3 months)
- KRW 455.5 million
- Revenue (year to date)
- KRW 1.6 billion
- Operating profit (prior-year 3 months)
- KRW -2.3 billion
- Operating profit (year to date)
- KRW -9.4 billion
- Net income (prior-year 3 months)
- KRW -2.3 billion
- Net income (year to date)
- KRW -10.0 billion
Commentary
AI commentary · Not investment advice
What happened
Synteca Bio filed its quarterly report for the third quarter of 2026, on a consolidated basis. Sales for the latest 3 months were KRW 689.3 million. That is 51.3% more than the same 3 months a year earlier, when sales were KRW 455.5 million.
In the company's terms
Operating profit (profit from the core business) for the 3 months was a loss of KRW 3.67 billion. A year earlier it was a loss of KRW 2.31 billion. Net income (the final profit after taxes and other items) for the 3 months was a loss of KRW 4.30 billion. A year earlier it was a loss of KRW 2.30 billion.
What changes for shareholders
For the year to date (January 1 to September 30), sales were KRW 1.56 billion. Operating profit was a loss of KRW 9.40 billion. Net income was a loss of KRW 10.0 billion. The report lists no upcoming events.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
S